Recruiting PHASE4 Alcohol Use Disorder

Tests treatment safety and results for Alcohol Use Disorder

Official title Sex Differences in Trauma, Inflammation and Brain Function and the Implications for Treatment Efficacy in Alcohol Use Disorder

ClinicalTrials.gov ID: NCT06426303

What this study is testing

What is Naltrexone?

Naltrexone is an investigational medicine, given as an once-weekly, being studied as a potential treatment for alcohol use disorder.

Also referred to as Revia.

Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.

What it's testing
The goal of this clinical trial is to identify sex-specific biomarkers that confer greater susceptibility for Alcohol Use Disorder (AUD) and differentiate how treatment response varies by sex in people with Alcohol Use Disorder. The main questions it aims to answer are: How does trauma affect emotion regulation, inflammation, and limbic function, and what are the sex-dependent effects of NTX (Naltrexone) on these aspects?
  • Phase 4: studies an already-approved treatment
  • You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 to 60. Healthy volunteers may be eligible.

You may be able to join if

  • 18-60 years old
  • Veteran enrolled in VHA healthcare Alcohol Group:
  • must meet diagnosis for recent alcohol-use disorder (DSM-V)
  • willing to return for follow-up visits and can participate for 12-weeks Control Group:
  • must not meet DSM-V criteria for a use disorder other than nicotine

You likely can't join if

  • Clinically significant neurological, endocrine, hepatic, or systemic disease that would compromise safe participation or confound outcomes
  • Left-handedness
  • Axis-1 psychiatric diagnoses other than anxiety, depression or post-traumatic stress disorder
  • Recreational or prescriptive use of psychotropic medications
  • Recreational or prescriptive use of opioid medications or have a past or current history of abuse or dependence on opioids
  • MRI contraindications (e.g. metal in body)
See the full eligibility criteria
Who can join
  • 18-60 years old
  • Veteran enrolled in VHA healthcare Alcohol Group:
  • must meet diagnosis for recent alcohol-use disorder (DSM-V)
  • willing to return for follow-up visits and can participate for 12-weeks Control Group:
  • must not meet DSM-V criteria for a use disorder other than nicotine
What rules you out
  • Clinically significant neurological, endocrine, hepatic, or systemic disease that would compromise safe participation or confound outcomes
  • Left-handedness
  • Axis-1 psychiatric diagnoses other than anxiety, depression or post-traumatic stress disorder
  • Recreational or prescriptive use of psychotropic medications
  • Recreational or prescriptive use of opioid medications or have a past or current history of abuse or dependence on opioids
  • MRI contraindications (e.g. metal in body)
  • Positive urine drug screen, except for nicotine and marijuana, on test days
  • Women who are pregnant or breastfeeding
  • Participants on hormonal therapy or treatments other than pregnancy contraceptives
  • Autoimmune or neurodegenerative diseases that present with neuroinflammation (multiple sclerosis, amyotrophic lateral sclerosis, Alzheimer's, Parkinson's)
  • Current participation in an investigational drug study
  • Alcohol group: \ 3 weeks of abstinence from alcohol
  • Alcohol group: Liver disease requiring medication or medical treatment, and/or aspartate or alanine aminotransferase levels greater than 3 times the upper limit of normal, gastrointestinal or renal disease that would...
  • Non-english speaker

The study team makes the final eligibility decision.

Where it's taking place

  • Portland, Oregon, United States

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years to 60 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Portland, Oregon, United States. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.